Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas

Martin J. van den Bent, Jeffrey S. Wefel, Nicholas D. Schiff, Martin J. B. Taphoorn, Kurt A. Jaeckle, L. Junck, Terri S. Armstrong, A. Choucair, Adam D. Waldman, Thierry Gorlia, M. Chamberlain, B. G. Baumert, Michael A. Vogelbaum, David R. Macdonald, D. A. Reardon, Patrick Y. Wen, Susan M. Chang, A. H. Jacobs

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)583-593
JournalLancet oncology
Volume12
Issue number6
DOIs
Publication statusPublished - Jun 2011

Cite this

van den Bent, M. J., Wefel, J. S., Schiff, N. D., Taphoorn, M. J. B., Jaeckle, K. A., Junck, L., Armstrong, T. S., Choucair, A., Waldman, A. D., Gorlia, T., Chamberlain, M., Baumert, B. G., Vogelbaum, M. A., Macdonald, D. R., Reardon, D. A., Wen, P. Y., Chang, S. M., & Jacobs, A. H. (2011). Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet oncology, 12(6), 583-593. https://doi.org/10.1016/S1470-2045(11)70057-2